Kaloba (Pelargonium Sidoides Root Liquid Extraction Preparation (1 : 8-10), Extraction Solvent: Ethanol 11 %)

Pelargonium sidoides extract contains bioactive compounds that exhibit antibacterial, antiviral and immunomodulatory properties. It is believed to stimulate macrophage activity, increase interferon production, enhance mucociliary clearance, and inhibit pathogen adhesion to respiratory epithelium, thereby supporting the body’s natural defense mechanisms.

The appropriate dose of Kaloba is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and local guidelines. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for Kaloba during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Kaloba, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kaloba’s active ingredient, Pelargonium sidoides, is distinguished by its documented antibacterial, antiviral and immunomodulatory effects, whereas many other herbal remedies rely primarily on symptomatic relief. Clinical studies suggest Kaloba may reduce cough duration more effectively than some single‑herb preparations, but comparative efficacy varies with formulation and patient population.

Kaloba should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from moisture and direct sunlight, and keep it out of reach of children.

Kaloba is taken orally as a liquid preparation. The prescribed dose is measured with the supplied dropper or measuring device and swallowed. It can be taken with or without food, according to the prescriber’s guidance.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, liver enzyme elevations indicating possible hepatotoxicity, and rare blood disorders like thrombocytopenia. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, jaundice, or unexplained bruising.

Kaloba should be avoided by individuals with known hypersensitivity to Pelargonium sidoides or any component of the formulation. It is also contraindicated in patients with severe liver disease, uncontrolled autoimmune conditions, or those taking medications that may interact severely without appropriate monitoring.